Literature DB >> 3494718

Monoclonal antibodies that distinguish between class II antigens (HLA-DP, DQ, and DR) in 14 haplotypes.

P A Robbins, E L Evans, A H Ding, N L Warner, F M Brodsky.   

Abstract

The specificity of three commonly used monoclonal antibodies (MoAbs) reacting with human class II histocompatibility antigens, was analyzed to determine whether these MoAbs would distinguish between HLA-DP, DQ, and DR in a large number of haplotypes. The reactivity of these MoAbs (L243, Anti-Leu 10, and B7/21) was compared by serial immunoprecipitation of class II antigens from 11 B-cell lines. The cell lines examined expressed a total of five DP, three DQ, and nine DR types, which together represent most of the well-defined class II specificities. This is the first demonstration that one of these antibodies, B7/21. binds to at least five DP specificities, and does not bind to DR or DQ molecules as defined by reactivity with the two other MoAbs. Within the scope of these experiments, the B7/21 antibody was shown to react with a monomorphic DP determinant. A variant clone of the B7/21 hybridoma was isolated that secretes IgG1 antibody with the same specificity as the original IgG3 antibody. The two other antibodies studied have been previously shown to react with DR molecules (L243) or DQ molecules (Anti-Leu 10). Here, their lack of cross-reaction with DP molecules is demonstrated. Thus, each of the three MoAbs reacts exclusively with a distinct class II molecule in all haplotypes studied, and therefore should be useful for comparing the independent expression and function of DP, DQ, and DR molecules.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3494718     DOI: 10.1016/0198-8859(87)90077-2

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  19 in total

1.  DM influences the abundance of major histocompatibility complex class II alleles with low affinity for class II-associated invariant chain peptides via multiple mechanisms.

Authors:  Cornelia H Rinderknecht; Sujin Roh; Achal Pashine; Michael P Belmares; Namrata S Patil; Ning Lu; Phi Truong; Tieying Hou; Claudia Macaubas; Taejin Yoon; Nan Wang; Robert Busch; Elizabeth D Mellins
Journal:  Immunology       Date:  2010-04-12       Impact factor: 7.397

2.  Class II MHC antigen presentation defect in neonatal monocytes is not correlated with decreased MHC-II expression.

Authors:  David H Canaday; Soma Chakravarti; Tarun Srivastava; Daniel J Tisch; Vinay K Cheruvu; Jamie Smialek; Clifford V Harding; Lakshmi Ramachandra
Journal:  Cell Immunol       Date:  2007-02-26       Impact factor: 4.868

3.  Immunological changes among workers occupationally exposed to styrene.

Authors:  E Bergamaschi; A Smargiassi; A Mutti; I Franchini; R Lucchini
Journal:  Int Arch Occup Environ Health       Date:  1995       Impact factor: 3.015

4.  Differential regulation of Th1 and Th2 cells by p91-110 and p21-40 peptides of the 16-kD alpha-crystallin antigen of Mycobacterium tuberculosis.

Authors:  J N Agrewala; R J Wilkinson
Journal:  Clin Exp Immunol       Date:  1998-12       Impact factor: 4.330

5.  Presentation of an immunodominant T-cell epitope of hepatitis B surface antigen by the HLA-DPw4 molecule.

Authors:  E Celis; R W Karr
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

6.  Peptide-mediated modulation of T-cell allorecognition.

Authors:  D D Eckels; J Gorski; J Rothbard; J R Lamb
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

7.  Critical role for the Val/Gly86 HLA-DR beta dimorphism in autoantigen presentation to human T cells.

Authors:  B Ong; N Willcox; P Wordsworth; D Beeson; A Vincent; D Altmann; J S Lanchbury; G C Harcourt; J I Bell; J Newsom-Davis
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

8.  Immunodominant CD4+ responses identified in a patient vaccinated with full-length NY-ESO-1 formulated with ISCOMATRIX adjuvant.

Authors:  Qiyuan Chen; Heather Jackson; Phillip Parente; Tina Luke; Mark Rizkalla; Tsin Yee Tai; He-Cheng Zhu; Nicole A Mifsud; Nektaria Dimopoulos; Kelly-Anne Masterman; Wendie Hopkins; Heather Goldie; Eugene Maraskovsky; Simon Green; Lena Miloradovic; James McCluskey; Lloyd J Old; Ian D Davis; Jonathan Cebon; Weisan Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-14       Impact factor: 11.205

9.  Macrophages, microglial cells, and HLA-DR antigens in fetal and infant brain.

Authors:  M M Esiri; M S al Izzi; M C Reading
Journal:  J Clin Pathol       Date:  1991-02       Impact factor: 3.411

10.  Expression of HLA-DR4 and human CD4 transgenes in mice determines the variable region beta-chain T-cell repertoire and mediates an HLA-DR-restricted immune response.

Authors:  L Fugger; S A Michie; I Rulifson; C B Lock; G S McDevitt
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-21       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.